Modeling motivational deficits in mouse models of schizophrenia: Behavior analysis as a guide for neuroscience

Behavioural Processes

Volumn 87, Issue 1, 2011, Pages 149-156

  Ward, Ryan D ^a,b   Simpson, Eleanor H ^a,b,c   Kandel, Eric R ^a,c,d,e,f   Balsam, Peter D ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c Center for Neurobiology and Behavior   (United States)

^d Department of Neuroscience ^*  (United States)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^f College of Physicians and Surgeons of Columbia University ^*  (United States)

Author keywords

Animal models; Dopamine D2 receptors; Motivation; Schizophrenia; Transgenic mice

Indexed keywords

DOPAMINE 2 RECEPTOR;

BEHAVIORAL ECOLOGY; DISEASE PREVALENCE; DISEASE TREATMENT; EXPERIMENTAL STUDY; GENETICALLY MODIFIED ORGANISM; LITERATURE REVIEW; MOLECULAR ANALYSIS; NEUROLOGY; NUMERICAL MODEL; PHENOTYPE; RODENT;

ARTICLE; BEHAVIOR; BEHAVIORAL SCIENCE; DISEASE MODEL; DOPAMINERGIC TRANSMISSION; GENETICS; HUMAN; MOTIVATION; MOUSE; NEGATIVE SYNDROME; NEUROSCIENCE; NONHUMAN; SCHIZOPHRENIA;

ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; MICE; MOTIVATION; SCHIZOPHRENIA;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 79954974230     PISSN: 03766357     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beproc.2011.02.004     Document Type: Article

References (73)

1. Abi-Dargham A., Rodenhiser J., Printz D., Zea-Ponce Y., Gil R., Kegeles L.S., Weiss R., Cooper T.B., Mann J.J., Van Heertum R.L., Gorman J.M., Laruelle M. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:8104-8109.
2. Aiba A., Nakao H. Conditional mutant mice using tetracycline-controlled gene expression system in the brain. Neurosci. Res. 2007, 58:113-117.
3. Allen N.C., Bagade S., McQueen M.B., Ioannidis J.P.A., Kavvoura F.K., Khoury M.J., Tanzi R.E., Bertram L. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat. Genet. 2008, 40:827-834.
4. Arguello P.A., Gogos J.A. Modeling madness in mice: one piece at a time. Neuron 2006, 52:179-196.
5. Bach M.E., Simpson E.H., Kahn L., Marshall J.J., Kandel E.R., Kellendonk C. Transient and selective overexpression of D2 receptors in the striatum causes persistent deficits in conditional associative learning. Proc. Natl. Acad. Sci. 2008, 105:16027-16032.
6. Barch D.M., Dowd E.C. Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions. Schizophrenia Bull. 2010, 36:919-934.
7. Beng-Choon H., Nopoulos P., Flaum M., Arndt S., Andreason N.C. Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life. Am. J. Psychiat. 1998, 155:1196-1201.
8. Berridge K.C., Robinson T.E. Parsing reward. Trends Neurosci. 2003, 26:507-513.
9. Bleuler E. Dementia Praecox or the Group of Schizophrenias 1950, International Universities Press, New York.
10. Clausen J. An evaluation of experimental methods of time judgment. J. Exp. Psychol. 1950, 40:76-761.
11. Corcoran C., Davidson L., Sills-Shahar R., Nickou C., Malaspina D., Miller T., McGlashan T. A qualitative research study on the evolution of symptoms in individuals identified as prodromal to psychosis. Psychiat. Quart. 2003, 74:313-332.
12. Davalos D.B., Kinsley M.A., Ross R.G. Effects of interval duration on temporal processing in schizophrenia. Brain Cogn. 2003, 52:295-301.
13. Davis K.L., Kahn R.S., Ko G., Davidson M. Dopamine in schizophrenia: a review and reconceptualization. Am. J. Psychiat. 1991, 148:1474-1486.
14. Densen M.E. Time perception and schizophrenia. Percept. Motor Skill. 1977, 44:436-438.
15. Drew M.R., Simpson E.H., Kellendonk C., Herzberg W.G., Lipatova O., Fairhurst S., Kandel E.R., Malapani C., Balsam P.D. Transient overexpression of striatal D2 receptors impairs operant motivation and interval timing. J. Neurosci. 2007, 27:7731-7739.
16. Elvevåg B., McCormack T., Gilbert A., Brown G.D.A., Weinberger D.R., Goldberg T.E. Duration judgments in patients with schizophrenia. Psychol. Med. 2003, 33:1249-1261.
17. Elvevåg B., Brown G.D.A., McCormack T., Vousden J.I., Goldberg T.E. Identification of tone duration, line length, and letter position: an experimental approach to timing and working memory deficits in schizophrenia. J. Abnorm. Psychol. 2004, 113:509-521.
18. Frankle W.G. Neuroreceptor imaging studies in schizophrenia. Harvard Rev. Psychiat. 2007, 15:212-232.
19. Galtress T., Kirkpatrick K. Reward value effects on timing in the peak procedure. Learn. Motiv. 2009, 40:109-131.
20. Gard D.E., Kring A.M., Gard M.G., Horan W.P., Green M.F. Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure. Schizophrenia Res. 2007, 93:253-260.
21. Heerey E.A., Gold J.M. Patients with schizophrenia demonstrate dissociation between affective experience and motivated behavior. J. Abnorm. Psychol. 2007, 116:268-278.
22. Hodos W. Progressive ratio as a measure of reward strength. Science 1961, 134:943-944.
23. Howes O.D., Kapur S. The dopamine hypothesis of schizophrenia: version III-the final common pathway. Schizophrenia Bull. 2009, 35:549-562.
24. Howes O.D., Montgomery A.J., Asselin M.C., Murray R.M., Valli I., Tabraham P., Braman- Bosch E., Valmaggia L., Johns L., Broome M., McGuire P.K., Grasby P.M. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch. Gen. Psychiat. 2009, 66:13-20.
25. Johnson J.E., Petzel T.P. Temporal orientation and time estimation in chronic schizophrenics. J. Clin. Psychol. 1971, 27:194-196.
26. Karayiorgou M., Simon T.J., Gogos J.A. 22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia. Nat. Rev. Neurosci. 2010, 11:402-416.
27. Kellendonk C. Modeling excess striatal D2 receptors in mice. Progress in Brain Research 2009, Elsevier. A. Sawa (Ed.).
28. Kellendonk C., Simpson E.H., Kandel E.R. Modeling cognitive endophenotypes of schizophrenia in mice. Trends Neurosci. 2009, 32:347-358.
29. Kellendonk C., Simpson E.H., Polan H.J., Malleret G., Vronskaya S., Winiger V., Moore H.M., Kandel E.R. Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 2006, 49:603-615.
30. Kirkpatrick B., Fenton W.S., Carpenter W.T., Marder S.R. The NIMH matrics consensus statement on negative symptoms. Schizophrenia Bull. 2006, 32:214-219.
31. Kraepelin E. Dementia Praecox and Paraphrenia 1919, Livingstone, Edinburgh, Scotland.
32. Kremen W.S., Seidman L.J., Faraone S.V., Toomey R., Tsuang M.T. The paradox of normal neuropsychological function in schizophrenia. J. Abnorm. Psychol. 2000, 109:743-752.
33. Laruelle M. Imaging dopamine transmission in schizophrenia: a review and meta-analysis. Q. J. Nucl. Med. 1998, 42:211-221.
34. Lattal K.A., Reilly M.P., Kohn J.P. Response persistence under ratio and interval schedules of reinforcement. J. Exp. Anal. Behav. 1998, 70:165-183.
35. Lewis D.A., Lieberman J.A. Catching up on schizophrenia: natural history and neurobiology. Neuron 2000, 28:325-334.
36. Lhamon L.T., Goldstone S. The time sense: estimation of one second durations by schizophrenic patients. Arch. Neurol. Psychiat. 1956, 76:625-629.
37. Lieberman J.A., Perkins D., Belger A., Chakos M., Jarskog F., Boteva K., Gilmore J. The early stages of schizophrenia: speculation on pathogenesis, pathophysiology, and therapeutic approaches. Biol. Psychiat. 2001, 50:884-897.
38. Ludvig E.A., Conover K., Shizgal P. The effects of reinforcer magnitude on timing in rats. J. Exp. Anal. Behav. 2007, 87:201-218.
39. Mayford M., Bach M.E., Huang Y.Y., Wang L., Hawkins R.D., Kandel E.R. Control of memory formation through regulated expression of a camkII transgene. Science 1996, 274:1678-1683.
40. McClellan J.M., Susser E., King M. Schizophrenia: a common disease caused by multiple rare alleles. Br. J. Psychiat. 2007, 190:194-199.
41. Meyer-Lindenberg A.S., Olsen R.K., Kohn P.D., Brown T., Egan M.F., Weinberger D.R., Berman K.F. Regionally specific disturbance of dorsolateral prefrontal-hippocampal functional connectivity in schizophrenia. Arch. Gen. Psychiat. 2005, 62:379-386.
42. Morozov A., Kellendonk C., Simpson E., Tronche F. Using conditional mutagenesis to study the brain. Biol. Psychiat. 2003, 54:1125-1133.
43. Niendam T.A., Jalbrzikowski M., Beardon C.E. Exploring predictors of outcome in the psychosis prodrome: implications for early identification and intervention. Neuropsychol. Rev. 2009, 19:280-293.
44. O'Tuathaigh C.M.P., Kirby B.P., Moran P.M., Waddington J.L. Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophrenia. Schizophrenia Bull. 2010, 36:271-288.
45. Powell C.M., Miyakawa T. Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder?. Biol. Psychiat. 2006, 59:1198-1207.
46. Richards, V.L., Simpson, E.H., Kellendonk, C., Taylor, K.M., Ward, R.D., Kandel, E.R., Balsam, P.D., 2009. Characterization of the motivational deficit induced by striatal D2 receptor overexpression in mice. In: Poster Presented at the Annual Meeting of the Society for Neuroscience, Chicago, IL (October).
47. Roberts S. Isolation of an internal clock. J. Exp. Psychol. Anim. B 1981, 7:242-268.
48. Roth T.L., Lubin F.D., Sodhi M., Kleinman J.E. Epigenetic mechanisms in schizophrenia. Biochim. Biophys. Acta 2009, 1790:869-877.
49. Salamone J.D., Correa M., Farrar A., Mingote S.M. Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits. Psychopharmacology 2007, 191:461-482.
50. Salamone J.D., Correa M., Farrar A.M., Nunes E.J., Pardo M. Dopamine, behavioral economics, and effort. Frontiers in Behavioral Neuroscience 2009, 3:13.
51. Salamone J.D., Correa M. Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine. Behav. Brain Res. 2002, 137:3-25.
52. Salamone J.D., Cousins M.S., Snyder B.J. Behavioral functions of nucleus accumbens dopamine: empirical and conceptual problems with the anhedonia hypothesis. Neurosc. Biobehav. Rev. 1997, 21:341-359.
53. Salamone J.D., Cousins M.S., Maio C., Champion M., Turski T., Kovach J. Different behavioral effects of haloperidol, clozapine and thioridazine in a concurrent lever pressing and feeding procedure. Psychopharmacology 1996, 125:105-112.
54. Salamone J.D., Steinpreis R.E., McCullough L.D., Smith P., Grebel D., Mahan K. Haloperidol and nucleus accumbens dopamine depletion suppress lever pressing for food but increase free food consumption in a novel food choice procedure. Psychopharmacology 1991, 104:515-521.
55. Sauer B. Inducible gene targeting in mice using the Cre/lox system. Methods 1998, 14:381-392.
56. Seeman P., Lee T., Chau-Wong M., Wong K. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 1976, 261:717-719.
57. Sigurdsson T., Stark K.L., Karayiorgou M., Gogos J.A., Gordon J.A. Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia. Nature 2010, 464:763-767.
58. Simpson, E.H., Kellendonk, C., Ward, R.D., Richards, V.L., Lipatova, O., Fairhurst, S., Moore, H., Kandel, E.R., Balsam, P.D., in press. Pharmacologic rescue of motivational deficit in an animal model of the negative symptoms of schizophrenia. Biol. Psychiat.
59. Skinner B.F. The science of human behavior 1953, Macmillan, New York.
60. Skinner B.F. About behaviorism 1974, Vintage, New York.
61. Skinner B.F. Why I am not a cognitive psychologist. Behaviorism. 1977, 5:1-10.
62. Skinner B.F. Cognitive science and behaviorism. Brit. J. Psychol. 1985, 76:291-301.
63. Tanaka K.F., Ahmari S.E., Leonardo E.D., Richardson-Jones J.W., Budreck E.C., Scheiffele P., Sugio S., Inamura N., Ikenaka K., Hen R. Flexible Accelerated STOP Tetracycline Operator-knockin (FAST): a versatile and efficient new gene modulating system. Biol. Psychiat. 2010, 67:770-773.
64. Taylor M.A. Are schizophrenia and affective disorder related? Am. J. Psychiat. 1992, 149:22-32.
65. Todd J. Impaired detection of silent interval change in schizophrenia. Neuroreport 2006, 17:785-789.
66. Tsuang M. Schizophrenia: Genes and environment. Biol. Psychiat. 2000, 47:210-220.
67. Tysk L. Estimation of time and the subclassification of schizophrenic disorders. Percept. Motor Skill. 1983, 57:911-918.
68. Tysk L. A longitudinal study of time estimation in psychotic disorders. Percept. Motor Skill. 1984, 5:779-789.
69. Tysk L. Estimation of time by patients with positive and negative schizophrenia. Percept. Motor Skill. 1990, 71:826.
70. Vallone D., Picetti R., Borelli E. Structure and function of dopamine receptors. Neurosci. Biobehav. Rev. 2000, 24:125-132.
71. Ward R., Kellendonk C., Simpson E.H., Lipatova O., Drew M.R., Fairhurst S., Kandel E.R., Balsam P.D. Impaired timing precision produced by striatal D2 receptor overexpression is mediated by cognitive and motivational deficits. Behav. Neurosci. 2009, 123:720-730.
72. Watson Psychology as the behaviorist views it. Repr. Psychol. Rev. 1913, 101:248-253.
73. Yang Y.K., Yeh T.L., Chiu N.T., Lee I.H., Chen P.S., Lee L.C., Jeffries K.J. Association between cognitive performance and striatal dopamine binding is higher in timing and motor tasks in patients with schizophrenia. Psychiat. Res. 2004, 131:209-216.